Effectiveness of mRNA vaccines against the Alpha and Beta variants in France

(Institut Pasteur) Scientists from the Institut Pasteur, in collaboration with the French National Health Insurance Fund (CNAM), Ipsos and Santé publique France showed that the two-dose vaccination regimen of mRNA vaccines provides 88% protection against non-variant virus, 86% against the Alpha variant and 77% against the Beta variant. The results of this study were published in The Lancet Regional Health Europe on July 14, 2021